Clip
Rethinking GLP-1 Drugs for Weight Loss and Long-Term Health
“In STEP 1, once-weekly semaglutide plus lifestyle support produced an average weight reduction of 14.9% over 68 weeks, compared with 2.4% with placebo, establishing strong efficacy for selected adults with overweight or obesity.”